Ex Parte Hoppenstein - Page 3


                  Appeal Number:  2006-2941                                                                                    
                  Application Number:  10/170,421                                                                              

                  well known to skilled persons in June 2002. . . . [, and] it would have been abundantly                      
                  clear to such skilled persons that the distributed excesses are calculated using a                           
                  computer.”                                                                                                   
                          We agree with appellant.  It is well-established that “[a]n inventor need not . . .                  
                  explain every detail since he is speaking to those skilled in the art. What is conventional                  
                  knowledge will be read into the disclosure.”  In re Howarth, 654 F.2d 103, 105; 210                          
                  USPQ 689, 691 (C.C.P.A. 1981).  Appellant, throughout the specification, describes the                       
                  invention as it applies to HMOs, which may have over 100 million members (see, for                           
                  example, page 11, lines 5-7).  Further, in the example on page 11 of the specification, the                  
                  amount of money going into the fund is $16 per member, or over one and a half billion                        
                  dollars.  In other words, the calculations referenced in the claims may involve billions of                  
                  dollars divided amongst millions of members.  Computers have long been used for                              
                  calculations involving such large numbers.  Thus, the use of a computer to calculate                         
                  excesses in the fund is considered conventional knowledge that will be read into the                         
                  disclosure and need not be detailed in the specification.  Accordingly, we will not sustain                  
                  the written description rejection of claims 1, 2, 4 through 14, and 16 through 22.                           
                          The examiner (Answer, page 3) further rejects claims 1, 4 through 6, 8, 10                           
                  through 14, and 16 through 22 as being unpatentable over Halley.  Specifically, the                          
                  examiner (Answer, page 4) asserts that Halley discloses all of the limitations of claim 1                    
                  except for the recited accounting period.  However, the examiner contends that using an                      
                  accounting period is “known and used as a business choice to establish an optimized way                      
                  of accounting for a particular business set-up.”  The examiner concludes (Answer, pages                      
                  4-5) that it would have been obvious to include a timely payment schedule in Halley                          
                  “which is best for business profitability.”                                                                  
                          Appellant argues (Brief, page 9) that Halley fails to teach paying into a fund,                      
                  calculating liabilities against participants of the fund, and paying the established                         
                  liabilities out of the fund, all with reference to a defined accounting period, nor                          
                  distributing excesses to participants.  Appellant explains (Brief, page 9) that the timing of                
                  Halley’s pay-outs depends on the employee’s death, disability, or retirement, not on a                       
                  defined accounting period.                                                                                   


                                                              3                                                                



Page:  Previous  1  2  3  4  5  6  7  Next 

Last modified: November 3, 2007